Women with COPD by biomass show different serum profile of adipokines, incretins, and peptide hormones than smokers.

Respir Res

Departamento de Investigación en Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INERICV), Talpan 4502, C.P. 14080, Ciudad de México, Mexico.

Published: December 2018

Background: The main causes of COPD are tobacco smoking (COPD-TS) and biomass smoke exposure (COPD-BS). COPD-TS is known to induce changes in adipokines, incretins, and peptide hormones, frequent biomarkers of inflammation; however, it is unknown if similar changes occur in COPD-BS.

Methods: Clinical and physiological characteristics, and serum concentration of C-peptide, ghrelin, GIP, GLP-1, glucagon, insulin, leptin, PAI-1, resistin, and visfatin were measured in women with COPD-BS, COPD-TS, and healthy controls. Data were compared with one-way ANOVA and Tukey's post hoc test; nonparametric were expressed as median (interquartile ranges), with Kruskal-Wallis and Dunn's post-hoc test. Multivariate analysis, age, BMI, MS, and FEV% pred with levels of inflammatory mediators in COPD women.

Results: FEV1% pred, FVC% pred, and FEV1/FVC ratio were decremented in COPD. In COPD-TS increased C-peptide, ghrelin, GIP, GLP-1, and leptin, and reduced glucagon, PAI-1, resistin, and visfatin. In COPD-BS enlarged ghrelin, insulin, leptin, and PAI-1 comparatively with COPD-TS and control, while C-peptide and GLP-1 relatively with controls; conversely, glucagon, and resistin were reduced. Multivariate analysis showed association of ghrelin, insulin, PAI-1, and visfatin with BS exposure.

Conclusions: women with COPD-BS have a distinct profile of adipokines, incretins, and peptide hormones, and specifically with ghrelin, insulin, PAI-1, and visfatin related to BS exposure.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280373PMC
http://dx.doi.org/10.1186/s12931-018-0943-4DOI Listing

Publication Analysis

Top Keywords

adipokines incretins
12
incretins peptide
12
peptide hormones
12
ghrelin insulin
12
profile adipokines
8
copd-bs copd-ts
8
c-peptide ghrelin
8
ghrelin gip
8
gip glp-1
8
insulin leptin
8

Similar Publications

We investigate the role of homeostatic mechanisms involved in acute, postprandial nutrient metabolism and nutrient-induced systemic inflammation in CKD presence and progression in Metabolic dysfunction-associated steatohepatitis (MASH). We assessed postprandial incretins (GLP-1 and GIP), intestinotropic hormone GLP-2, endotoxin LPS, Zonulin (a marker of intestinal permeability), hepatokines, adipokines and NF-kB activation in circulating MNCs during a meal tolerance test in 52 biopsy proven MASH patients randomized to curcumin Meriva or placebo and 26 matched controls. At baseline, MASH-CKD had a lower GLP-2 response and a 2-fold higher postprandial LPS and NF-kB activation in MNCs than MASH patients without CKD, but similar remaining postprandial or fasting parameters.

View Article and Find Full Text PDF
Article Synopsis
  • A study compared appetite regulation among Parkinson's Disease (PD) patients with cognitive impairment (CI), PD patients without CI, and age-matched controls to understand how these factors influence appetite.
  • Results showed that PD patients with CI consumed significantly less protein and had altered hormone levels, which were linked to decreased hunger and energy intake.
  • The hormones peptide YY (PYY) and glucagon-like peptide 1 (GLP-1) play key roles in appetite control for PD patients, suggesting they are important areas for further research.
View Article and Find Full Text PDF

Objective: To explore how metformin, alone or in conjunction with sitagliptin, affects the leptin/adiponectin ratio in obese type 2 diabetes mellitus patients.

Methods: The case-control study was conducted from March to August 2021 at the Department of Clinical Pharmacology, College of Medicine, Mustansiriyah University, Baghdad, Iraq, and comprised adult, obese type 2 diabetes mellitus patients of either gender and age-matched healthy controls. The MT group included patients taking metformin 1g/day, MTS group had patients taking metformin 1g/day plus sitagliptin 100mg/day, and the control group comprised healthy subjects.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the impact of two low-calorie, high-protein diets—one with animal protein (HPA) and one with plant protein (HPP)—on health outcomes for individuals with overweight, obesity, and glucose metabolism disorders.
  • A total of 117 participants were assigned to either diet for six months, with both diets including a balanced distribution of calories from fats and carbohydrates.
  • Results showed that both diets led to significant weight loss and improvements in body composition, glucose levels, and overall cardiometabolic health, regardless of whether the protein sources were plant or animal based.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!